Table 6 Prognostic factors toward survival (n = 45)

Age^#

56.51

12.04

54.83

16.14

0.832

Gender

Male

18

46.15

2

33.33

0.447

Female

21

53.85

4

66.67

Cancer Site

Splenic Flexure

2

5.13

0

0.00

0.152

Descending colon

8

20.51

1

16.67

Sigmoid

27

69.23

3

50.00

Rectosigmoid

2

5.13

2

33.33

Upfront surgery

25

64.10

3

50.00

0.407

SEMS

14

35.90

3

50.00

T stage

2

5

12.82

0

0.00

0.601

3

26

66.67

5

83.33

4

8

20.51

1

16.67

TNM stage

Stage 1

3

7.69

0

0.00

0.644

Stage 2

17

43.59

0

0.00

0.046*

Stage 3

19

48.72

6

100.00

0.022*

Positive LN

19

48.72

6

100.00

0.022*

< 12 lymph node dissected

3

7.69

6

100.00

0.644

Positive Lymph node^#

1.28

2.16

3.50

3.99

0.045*

Lymph node dissected^#

19.13

7.83

22.17

3.60

0.150

Perineural invasion

5

12.82

2

33.33

0.320

Lymphovascular invasion

5

12.82

2

33.33

0.320

Mucin production

4

10.26

0

0.00

0.552

SEMS to surgery in days^#

13.86

10.84

13.33

7.02

0.768

SEMS to surgery in > 14 days

5

12.82

1

16.67

0.728

Adjuvant chemotherapy

Yes

35

89.74

6

100.00

0.552

Approach of surgery

Laparoscopic

33

84.62

5

83.33

0.661

Converted to open

4

10.26

0

0.00

0.552

Open

6

15.38

1

16.67

0.661

Type of surgery

Total colectomy

1

2.56

1

16.67

0.252

Left hemicolectomy

13

33.33

1

16.67

0.382

Anterior resection

25

64.10

4

66.67

0.642

Distant metastasis

6

15.38

6

100.00

< 0.001*